You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 40 No. 3, March 1983 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  ORIGINAL CONTRIBUTIONS
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (38)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Creatine Kinase BB Isoenzyme in CSF in Neurologic Diseases

Measurement by Radioimmunoassay

Frederick E. Pfeiffer, MD; Henry A. Homburger, MD; Takehiko Yanagihara, MD

Arch Neurol. 1983;40(3):169-172.


Abstract



• The concentration of creatine kinase BB isoenzyme (CK BB) was measured by radioimmunoassay in CSF from 306 patients with various neurologic disorders. Levels above 2.0 ng/ml were not found in patients without neurologic disease. Whereas mean CSF CK BB level was less than 2.0 ng/mL in groups of patients with systemic malignant neoplasms, latent syphilis, peripheral neuropathy, disk disease, polyradiculopathy, myelopathy, multiple sclerosis, neurodegenerative disease, encephalopathy, and hydrocephalus, it was elevated in groups of patients with convulsive disorder, CNS neoplasm, cerebrovascular disease, vasculitis, and meningoencephalitis.



Author Affiliations



From the Departments of Neurology (Drs Pfeiffer and Yanagihara) and Laboratory Medicine (Dr Homburger), Mayo Clinic and Mayo Foundation, Rochester, Minn.


Footnotes



Accepted for publication April 15, 1982.

Reprint requests to Department of Neurology, Mayo Clinic, Rochester, MN 55905 (Dr Yanagihara).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Creatine kinase monitoring in sport medicine
Brancaccio et al.
Br Med Bull 2007;0:ldm014v1-22.
ABSTRACT | FULL TEXT  

Increased Creatine Kinase Brain Isoenzyme Concentration in Cerebrospinal Fluid with Meningitis
Nussinovitch et al.
CLIN PEDIATR 1996;35:349-351.
ABSTRACT  

Neurological Outcome After Out-of-Hospital Cardiac Arrest: Prediction by Cerebrospinal Fluid Enzyme Analysis
Roine et al.
Arch Neurol 1989;46:753-756.
ABSTRACT  

Serum Creatine Kinase B Concentrations in Acute Cerebrovascular Diseases
Pfeiffer et al.
Arch Neurol 1984;41:1175-1178.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1983 American Medical Association. All Rights Reserved.